Assisted Reproductive Techniques

Saturday, October 1, 2022, 7:57 AM - Tuesday, September 30, 2025, 12:00 AM


AMA PRA Category 1 Credits™ (25.00 hours), ABS CC (25.00 hours), Non-Physician Attendance (25.00 hours)

Management of infertility with assisted reproductive technology (ART) has changed substantially over the past ten to fifteen years due to the application of new technological advancements in this field and a better understanding of reproductive pathophysiology, particularly in female patients.

Thanks to this more in-depth and precise knowledge of gynecological endocrinology, new stimulation protocols have emerged, enabling fertility medicine practitioners to more easily adapt to patient-specific situations and minimize risks, resulting in an increased probability of having one healthy baby. Some tests, such as monogenic disease screening and preimplantation genetic testing (PGT), have also increased success rates. New technical advances have allowed oocytes in vitro maturation or oocyte/embryo vitrification to be achieved with a greater level of safety as well. In addition, embryos can be evaluated and selected in a more accurate way during in vitro fertilization (IVF) cycles thanks to the use of artificial intelligence.

Clinicians who treat patients with infertility can face several challenges, including selecting the appropriate treatment options for patients and managing complications that can arise from ART. Some treatment options, particularly those related to the incorporation of new ART techniques, are not well-known or well-understood within the community of OBGYN physicians and nurses. This educational program has been developed to provide an in-depth overview of the latest updates in ART.

1. Choose the most adequate preimplantation genetic test to perform an appropriate diagnosis.
2. - Plan an appropriate genetic counseling approach considering preimplantation genetic testing results.
3. Identify potential clinical applications of Germinal Vesicles (GV) rescue.
4. Discuss the best sperm selection technique for each patient.
5. Evaluate the use of Artificial Intelligence on embryo monitoring and assessment.
6. Explain the different drugs used in ovarian stimulation.
7. Choose the best ovarian stimulation protocol for each patient.
8. Choose the strategy during follicle growth depending on gonadotrophins.
9. Asses the best strategy to control estradiol secretion during follicular phase.
10. Choose the treatment strategy for complications of Assisted Reproduction Techniques.

To register for this activity, click here. By clicking on this link, you will be taken to the IVIRMA Global Education website.

Have questions or need learner support? Send an email to [email protected].

 

In support of improving patient care, this activity has been planned and implemented by Thomas Jefferson University and IVIRMA Global Education. Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physicians: This educational activity is designated for a maximum of 25.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals: This educational activity is designated for 25.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

 Jefferson Release Policy

Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy

As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Planning Committee
No planning committee members have any relevant financial relationships to disclose.

William Schlaff, MD
Juan Giles, MD, PhD

Faculty

 No member of the faculty have any relevant financial relationships to disclose.

Alfredo Guillén, MD
Fernando Bronet, PhD
Ana Cobo, PhD
Mª Jose Escriba, PhD
Mª José de los Santos, PhD
Marcos Meseguer, PhD
Anabel Salazar, MD
Juan Giles, MD, PhD
José Serna, MD, PhD
Israel Ortega, MD, PhD
Nicolás Garrido, PhD
Pilar Alamá, MD, PhD

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

 

This educational activity received no commercial or in-kind support.